1. Home
  2. CYBN vs TIL Comparison

CYBN vs TIL Comparison

Compare CYBN & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • TIL
  • Stock Information
  • Founded
  • CYBN 2019
  • TIL 2018
  • Country
  • CYBN Canada
  • TIL United States
  • Employees
  • CYBN N/A
  • TIL N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • TIL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CYBN Health Care
  • TIL Health Care
  • Exchange
  • CYBN Nasdaq
  • TIL Nasdaq
  • Market Cap
  • CYBN 176.0M
  • TIL 177.1M
  • IPO Year
  • CYBN N/A
  • TIL 2021
  • Fundamental
  • Price
  • CYBN $7.11
  • TIL $26.99
  • Analyst Decision
  • CYBN Strong Buy
  • TIL Buy
  • Analyst Count
  • CYBN 3
  • TIL 6
  • Target Price
  • CYBN $85.00
  • TIL $120.50
  • AVG Volume (30 Days)
  • CYBN 351.0K
  • TIL 145.0K
  • Earning Date
  • CYBN 08-13-2025
  • TIL 08-13-2025
  • Dividend Yield
  • CYBN N/A
  • TIL N/A
  • EPS Growth
  • CYBN N/A
  • TIL N/A
  • EPS
  • CYBN N/A
  • TIL N/A
  • Revenue
  • CYBN N/A
  • TIL N/A
  • Revenue This Year
  • CYBN N/A
  • TIL N/A
  • Revenue Next Year
  • CYBN N/A
  • TIL N/A
  • P/E Ratio
  • CYBN N/A
  • TIL N/A
  • Revenue Growth
  • CYBN N/A
  • TIL N/A
  • 52 Week Low
  • CYBN $4.81
  • TIL $10.80
  • 52 Week High
  • CYBN $13.88
  • TIL $92.00
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 45.43
  • TIL 50.40
  • Support Level
  • CYBN $6.36
  • TIL $23.82
  • Resistance Level
  • CYBN $7.75
  • TIL $30.19
  • Average True Range (ATR)
  • CYBN 0.34
  • TIL 2.34
  • MACD
  • CYBN -0.04
  • TIL -0.10
  • Stochastic Oscillator
  • CYBN 51.95
  • TIL 49.76

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: